Combination of EGFR-CAR NK-92 cells with herpes simplex virus 1-based oncolytic virus (oHSV-1) results in increased efficiency in killing a breast cancer cell line engrafted into the brain [116]. This evidence concerns the gene EGFR and breast carcinoma.